Atrial Fibrillation

This channel includes news and new technology innovations for the treatment of atrial fibrillation, also referred to as AF or afib. AF is a cardiac arrhythmia caused by irregular and often rapid heart rate. It is caused by the upper chambers (the atria) beating irregularly and uncoordinated with the lower  ventricle chambers of of the heart. Symptoms include weakness with heart palpitations and shortness of breath. The conditional can lead to an increased risk of stroke and heart failure. AF episodes can cause the blood in the atria to stagnate and form clots, usually within the left atrial appendage (LAA). The clots can flow to the brain and cause a stroke. Treatments include anticoagulation therapy to dissolve clots, catheter or surgical ablation and LAA occlusion

Feature

September 11, 2012 — Since the previous consensus document was published in 2007, catheter and surgical ablation of atri ...

Home September 11, 2012
Home
Feature

September 10, 2012 — Atrial fibrillation (AF) is a common complication of cardiac surgery, occurring in 10 to 40 percent ...

Home September 10, 2012
Home
Feature

August 30, 2012 — Baseline data from the first cohort of the Global Anticoagulant Registry in the Field (GARFIELD), an ...

Home August 30, 2012
Home
Feature

August 20, 2012 — The Baylor Heart Hospital in Plano, Texas, recently became the first hospital in the world to merge ...

Home August 20, 2012
Home
Feature

July 26, 2012 — A new study shows promising data for a new method to image the source of atrial fibrillation (AF) and ...

Home July 26, 2012
Home
Feature | Marianne Pop, Pharm.D., BCPS

Anticoagulants, primarily warfarin, are used to prevent thrombosis and thromboembolism in patients with atrial ...

Home July 12, 2012
Home
News

July 6, 2012 — Boston Scientific Corp. has completed enrollment in the PREVAIL confirmatory study, designed to gain U.S ...

Home July 06, 2012
Home
News

June 15, 2012 —Endosense, a pioneer and leader in force-sensing technology focused on improving the efficacy and safety ...

Home June 15, 2012
Home
News

June 11, 2012 — Boehringer Ingelheim Pharmaceuticals Inc. announced that the Pradaxa (dabigatran etexilate mesylate) ...

Home June 11, 2012
Home
Feature | Dave Fornell

The latest trends and newest cardiac rhythm management technology were highlighted during the biggest electrophysiology ...

Home May 24, 2012
Home
News

May 24, 2012 -- nContact Inc., a provider of  epicardial ablation devices, announced that new long-term physician data ...

Home May 24, 2012
Home
Videos | EP Lab

Diagnostic and Interventional Cardiology Editor Dave Fornell shows some of the most innovative new technology displayed ...

Home May 22, 2012
Home
Videos | EP Lab

Heart Rhythm Society (HRS) President-Elect Hugh Calkins, M.D., FACC, director, cardiac arrhythmia services and EP lab ...

Home May 17, 2012
Home
Feature | Dave Fornell

The current standard-of-care for catheter ablation of atrial fibrillation (AFib) patients includes up to six-hour long ...

Home May 17, 2012
Home
Subscribe Now